Elevance Health, Inc. — Director's Dealing 2021

Mar 3, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Anthem, Inc. (ANTM)
CIK: 0001156039
Period of Report: 2021-03-01

Reporting Person: Penczek Ronald W (SVP, Chief Accounting Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-03-01	Common Stock	F	818	$311.48	Disposed	2419	Direct
2021-03-01	Common Stock	A	322	—	Acquired	2741	Direct
2021-03-01	Common Stock	A	2573	—	Acquired	5314	Direct
2021-03-02	Common Stock	F	42	$311.66	Disposed	5272	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-03-01	Employee Stock Option (Right to Buy)	$311.48	A	1315	Acquired	2031-03-01	Common Stock (1315.0)	Direct

Footnotes

F1: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.

F2: Represents restricted share units. Restrictions lapse as follows: 107 shares each on 3/1/2022 and 3/1/2023, and 108 shares on 3/1/2024.

F3: Represents performance based restricted share units. Restrictions lapse on 3/1/2021.

F4: Balance includes 7.89 shares acquired on December 22, 2020 through a dividend reinvestment plan.

F5: The option represents a right to purchase a total of 1,315 shares, and is exercisable in three annual installments, with two installments of 438 shares each and one installment of 439 shares, beginning on 3/1/2022, which is the one-year anniversary of the option grant date.